Identification of T Cell Receptors Targeting a Neoantigen Derived from Recurrently Mutated FGFR3
Immunotherapies, including immune checkpoint blockades, play a critically important role in cancer treatments. For immunotherapies, neoantigens, which are generated by somatic mutations in cancer cells, are thought to be good targets due to their tumor specificity. Because neoantigens are unique in...
Main Authors: | Tomohiro Tate, Saki Matsumoto, Kensaku Nemoto, Matthias Leisegang, Satoshi Nagayama, Kazutaka Obama, Yusuke Nakamura, Kazuma Kiyotani |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/4/1031 |
Similar Items
-
Precision Medicine for Colorectal Cancer with Liquid Biopsy and Immunotherapy
by: Satoshi Nagayama, et al.
Published: (2021-09-01) -
Current Trends in Neoantigen-Based Cancer Vaccines
by: Szu-Ying Ho, et al.
Published: (2023-03-01) -
Neoantigen vaccine and neoantigen‐specific cell adoptive transfer therapy in solid tumors: Challenges and future directions
by: Yanwei Shen, et al.
Published: (2022-08-01) -
Identification of Shared Neoantigens in <i>BRCA1</i>-Related Breast Cancer
by: Lucksica Ruangapirom, et al.
Published: (2022-09-01) -
Artificial intelligence applied in neoantigen identification facilitates personalized cancer immunotherapy
by: Yu Cai, et al.
Published: (2023-01-01)